| [1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin，2020，70(1)：7-30.
|
| [2] |
Loibl S, Poortmans P, Morrow M, et al. Breast cancer[J]. The Lancet, 2021，397(10286)：1750-1769.
|
| [3] |
Fernández MF, Reina-Pérez I, Astorga JM, et al. Breast cancer and its relationship with the microbiota[J]. Int J Environ Res Public Health，2018，15(8)：1747.
|
| [4] |
Sepich-Poore GD, Zitvogel L, Straussman R, et al. The microbiome and human cancer[J]. Science，2021，371(6536): eabc4552.
|
| [5] |
Eslami-SZ, Majidzadeh-AK, Halvaei S, et al. Microbiome and breast cancer: new role for an ancient population[J]. Front Oncol，2020，10：120.
|
| [6] |
Thomas RM, Jobin C. The microbiome and cancer: is the oncobiome mirage real? [J]. Trends Cancer，2015，1(1)：24-35.
|
| [7] |
Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer[J]. Nature，575(7782)：299-309.
|
| [8] |
Wallace BD, Wang H, Lane KT, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme[J]. Science，2010, 330(6005)：831-835.
|
| [9] |
Jarman R, Ribeiro-Milograna S, Kalle W. Potential of the microbiome as a biomarker for early diagnosis and prognosis of breast cancer[J]. Breast Cancer，2020，23(6): 579-587.
|
| [10] |
Banerjee S, Tian T, Wei Z, et al. Distinct microbial signatures associated with different breast cancer types[J]. Front Microbiol，2018，9(1)：951.
|
| [11] |
Jost T，Lacroix C, Braegger C, et al. Impact of human milk bacteria and oligosaccharides on neonatal gut microbiota establishment and gut health[J]. Nutr Rev，2015，73(7)：426-437.
|
| [12] |
Chan AA, Bashir M, Rivas MN, et al. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors[J]. Sci Rep，2016，6(6)：28061.
|
| [13] |
Costantini L, Magno S, Albanese D, et al. Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions[J]. Sci Rep，2018，8(1)：16893.
|
| [14] |
Thompson KJ, Ingle JN, Tang X, et al. A comprehensive analysis of breast cancer microbiota and host gene expression[J]. PLoS ONE，2017，12(11)：e0188873.
|
| [15] |
Tina J, Chen J, Tanya L, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease[J]. Sci Rep，2016，6(8): 30751.
|
| [16] |
Tzeng A, Sangwan N, Jia M, et al. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer[J]. Genome Med，2021，13(1): 60.
|
| [17] |
Chiba A, Bawaneh A, Velazquez C, et al. Neoadjuvant chemotherapy shifts breast tumor microbiota populations to regulate drug responsiveness and the development of metastasis[J]. Mol Cancer Res，2020，18(1)：130-139.
|
| [18] |
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell，2011，144(5)：646-74.
|
| [19] |
Alpuim Costa D, Nobre JG, Batista MV, et al. Human microbiota and breast cancer-is there any relevant link? —a literature review and new horizons toward personalised medicine[J]. Front Microbiol，2021，12(2)：584332.
|
| [20] |
Gatti-Mays ME, Balko JM, Gameiro SR, et al. If we build it they will come: targeting the immune response to breast cancer[J]. NPJ Breast Cancer，2019，5(1)：37.
|
| [21] |
Ali HR, Provenzano E, Dawson SJ, et al. Association between CD8+ T-cell infiltration and breast cancer survival in 12439 patients[J]. Ann Oncol，2014，25(8)：1536-1543.
|
| [22] |
Safarzadeh E, Hashemzadeh S, Duijf PHG, et al. Circulating myeloid-derived suppressor cells: an independent prognostic factor in patients with breast cancer[J]. Cell Physiol，2019, 234(4): 3515-3525.
|
| [23] |
Pinto ML, Rios E, Durães C, et al. The two faces of tumor associated macrophages and their clinical significance in colorectal cancer[J]. Front Immunol，2019, 10(1)：1875.
|
| [24] |
Zhao X, Qu J, Sun Y, et al. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature[J]. Oncotarget，2017, 8(18)：30576-30586.
|
| [25] |
Parida S, Wu S, Siddharth S, et al. A pro-carcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes[J]. Cancer Discov，2021，11(5)：1138-1157.
|
| [26] |
Nejman D，Livyatan I，Fuks G，et al.The human tumor microbiome is composed of tumor type-specific intracellular bacteria[J]．Science，2020，368(6494)：973-980.
|
| [27] |
Parhi L, Alon-Maimon T, Sol A, et al. Breast cancer colonization by fusobacterium nucleatum accelerates tumor growth and metastatic progression[J]. Nat Commun，2020，11(1): 3259.
|
| [28] |
Gur C, Maalouf N, Shhadeh A, et al. Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1[J]. Oncoimmunology, 2019, 8(6)：e1581531.
|
| [29] |
Gopalakrishnan V, Helmink BA, Spencer CN, et al. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy[J]. Cancer Cell，2018，33(4)：570-580.
|
| [30] |
Raza MH, Gul K, Arshad A, et al. Microbiota in cancer development and treatment[J]. Cancer Res Clin Oncol，2019，145(1)：49-63.
|
| [31] |
Geier B, Sogin EM, Michellod D, et al. Spatial metabolomics of in situ host-microbe interactions at the micrometre scale[J]. Nat Microbiol，2020，5(3)：498-510.
|